19-kD抗原与结核病小鼠模型中的保护性免疫
The 19-kD antigen and protective immunity in a murine model of tuberculosis.
作者信息
Yeremeev V V, Lyadova I V, Nikonenko B V, Apt A S, Abou-Zeid C, Inwald J, Young D B
机构信息
Laboratory for Immunogenetics, Central Institute for Tuberculosis, Moscow, Russia.
出版信息
Clin Exp Immunol. 2000 May;120(2):274-9. doi: 10.1046/j.1365-2249.2000.01212.x.
Abstract
The 19-kD antigen is a cell wall-associated lipoprotein present in Mycobacterium tuberculosis and in bacille Calmette-Guérin (BCG) vaccine strains. Expression of the 19-kD antigen as a recombinant protein in two saprophytic mycobacteria-M. vaccae and M. smegmatis-resulted in abrogation of their ability to confer protection against M. tuberculosis in a murine challenge model, and in their ability to prime a DTH response to cross-reactive mycobacterial antigens. Induction of an immune response to the 19-kD antigen by an alternative approach of DNA vaccination had no effect on subsequent M. tuberculosis challenge. These results are consistent with a model in which the presence of the 19-kD protein has a detrimental effect on the efficacy of vaccination with live mycobacteria. Targeted inactivation of genes encoding selected antigens represents a potential route towards development of improved vaccine candidates.
摘要
19-kD抗原是一种与细胞壁相关的脂蛋白，存在于结核分枝杆菌和卡介苗（BCG）疫苗株中。在两种腐生分枝杆菌——母牛分枝杆菌和耻垢分枝杆菌中，将19-kD抗原表达为重组蛋白，导致它们在小鼠攻击模型中丧失了针对结核分枝杆菌的保护能力，以及引发对交叉反应性分枝杆菌抗原的迟发型超敏反应（DTH）的能力。通过DNA疫苗接种这一替代方法诱导对19-kD抗原的免疫反应，对随后的结核分枝杆菌攻击没有影响。这些结果与一个模型相符，即19-kD蛋白的存在对活分枝杆菌疫苗接种的效果有不利影响。对编码选定抗原的基因进行靶向失活，是开发改良候选疫苗的一条潜在途径。
相似文献
1
The 19-kD antigen and protective immunity in a murine model of tuberculosis.19-kD抗原与结核病小鼠模型中的保护性免疫
Clin Exp Immunol. 2000 May;120(2):274-9. doi: 10.1046/j.1365-2249.2000.01212.x.
2
Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.Ag85A-ESAT-6-IL-21 疫苗初免和卡介苗加强对小鼠结核分枝杆菌攻击的保护作用。
Int J Immunogenet. 2012 Apr;39(2):183-90. doi: 10.1111/j.1744-313X.2011.01066.x. Epub 2011 Dec 8.
3
Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.表达 ESAT6-CFP10 融合蛋白的重组耻垢分枝杆菌诱导抗分枝杆菌免疫应答，并保护小鼠免受结核分枝杆菌攻击。
Scand J Immunol. 2010 Oct;72(4):349-57. doi: 10.1111/j.1365-3083.2010.02448.x.
4
Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.卡介苗与表达ESAT-6和Ag85A融合蛋白的DNA疫苗初免-加强方案对小鼠结核病的免疫原性和保护效力
Clin Dev Immunol. 2011;2011:617892. doi: 10.1155/2011/617892. Epub 2011 Feb 27.
5
Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.用表达抗原Ag85B和Rv3425的慢病毒载体疫苗和DNA疫苗进行初免-加强卡介苗接种可提高小鼠对结核分枝杆菌的保护效力。
Immunology. 2014 Oct;143(2):277-86. doi: 10.1111/imm.12308.
6
Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.分泌白细胞介素-15/抗原85B融合蛋白的重组卡介苗在提供抗结核分枝杆菌保护方面的疗效
J Infect Dis. 2008 May 1;197(9):1263-74. doi: 10.1086/586902.
7
A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.一种表达 CFP21 和 MPT64 融合蛋白的 DNA 疫苗增强了卡介苗诱导的小鼠抗结核分枝杆菌感染的保护性免疫。
Med Microbiol Immunol. 2011 Aug;200(3):165-75. doi: 10.1007/s00430-011-0188-z. Epub 2011 Feb 22.
8
Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice.表面表达与 PE_PGRS33 的 PE 结构域融合的 MPT64 增强了牛分枝杆菌卡介苗对小鼠结核分枝杆菌的保护活性。
Infect Immun. 2010 Dec;78(12):5202-13. doi: 10.1128/IAI.00267-10. Epub 2010 Oct 4.
9
Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.分枝杆菌蛋白质组学在疫苗设计中的应用：牛分枝杆菌卡介苗初免-Rv3407 DNA加强免疫接种对结核病的保护作用增强
Infect Immun. 2004 Nov;72(11):6471-9. doi: 10.1128/IAI.72.11.6471-6479.2004.
10
Immune responses and protective efficacy induced by 85B antigen and early secreted antigenic target-6 kDa antigen fusion protein secreted by recombinant bacille Calmette-Guérin.重组卡介苗分泌的85B抗原与早期分泌性抗原靶标6 kDa抗原融合蛋白诱导的免疫反应及保护效果
Acta Biochim Biophys Sin (Shanghai). 2007 Apr;39(4):290-6. doi: 10.1111/j.1745-7270.2007.00281.x.
引用本文的文献
1
Stopping Tuberculosis at the Gate: The Role of Adhesins in Infection and Intervention.在源头遏制结核病：黏附素在感染与干预中的作用
Vaccines (Basel). 2025 Jun 24;13(7):676. doi: 10.3390/vaccines13070676.
2
DNA Subunit Vaccine and Recombinant BCG Based on Mycobacterial Lipoprotein LprO Enhance Anti-Tuberculosis Protection in the Lungs of Mice.基于分枝杆菌脂蛋白LprO的DNA亚单位疫苗和重组卡介苗增强小鼠肺部抗结核保护作用
Vaccines (Basel). 2025 Apr 11;13(4):400. doi: 10.3390/vaccines13040400.
3
In silico design of multi-epitope adhesin protein vaccines.多表位粘附素蛋白疫苗的计算机辅助设计
Heliyon. 2024 Sep 7;10(18):e37536. doi: 10.1016/j.heliyon.2024.e37536. eCollection 2024 Sep 30.
4
Prediction of Epitopes in Virulence Proteins of for Vaccine Designing.用于疫苗设计的[病原体名称]毒力蛋白中表位的预测 。（原文中“for Vaccine Designing”前缺少具体病原体名称，翻译时补充了[病原体名称]以使句子完整通顺）
Curr Genomics. 2021 Dec 31;22(7):512-525. doi: 10.2174/1389202922666211129113917.
5
Adhesion molecules facilitate host-pathogen interaction & mediate pathogenesis.黏附分子促进宿主-病原体相互作用并介导发病机制。
Indian J Med Res. 2019 Jul;150(1):23-32. doi: 10.4103/ijmr.IJMR_2055_16.
6
Scrutiny of Mycobacterium tuberculosis 19 kDa antigen proteoforms provides new insights in the lipoglycoprotein biogenesis paradigm.对结核分枝杆菌19 kDa抗原蛋白变体的详细研究为脂糖蛋白生物合成模式提供了新见解。
Sci Rep. 2017 Mar 8;7:43682. doi: 10.1038/srep43682.
7
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.一株重组耻垢分枝杆菌诱导针对结核分枝杆菌的强烈杀菌免疫。
Nat Med. 2011 Sep 4;17(10):1261-8. doi: 10.1038/nm.2420.
8
Impact of toll-like receptor 2 deficiency on immune responses to mycobacterial antigens.Toll 样受体 2 缺陷对分枝杆菌抗原免疫应答的影响。
Infect Immun. 2011 Nov;79(11):4649-56. doi: 10.1128/IAI.05724-11. Epub 2011 Aug 15.
9
Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.Zmp1介导的吞噬体成熟停滞的缓解与分枝杆菌抗原的呈递促进和免疫原性增强有关。
Clin Vaccine Immunol. 2011 Jun;18(6):907-13. doi: 10.1128/CVI.00015-11. Epub 2011 Apr 6.
10
Modulation of cell death by M. tuberculosis as a strategy for pathogen survival.结核分枝杆菌对细胞死亡的调控作为病原体生存的一种策略。
Clin Dev Immunol. 2011;2011:678570. doi: 10.1155/2011/678570. Epub 2011 Jan 4.
本文引用的文献
1
An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis.一项对从不感染结核分枝杆菌且对其敏感的I/St小鼠肺部回收的T淋巴细胞进行的体外研究。
Infect Immun. 1998 Oct;66(10):4981-8. doi: 10.1128/IAI.66.10.4981-4988.1998.
2
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.从全基因组序列解读结核分枝杆菌的生物学特性。
Nature. 1998 Jun 11;393(6685):537-44. doi: 10.1038/31159.
3
Identification of potential CD8+ T-cell epitopes of the 19 kDa and AhpC proteins from Mycobacterium tuberculosis. No evidence for CD8+ T-cell priming against the identified peptides after DNA-vaccination of mice.结核分枝杆菌19 kDa蛋白和AhpC蛋白潜在CD8+ T细胞表位的鉴定。小鼠经DNA疫苗接种后，未发现针对所鉴定肽段的CD8+ T细胞启动的证据。
Vaccine. 1998 Apr;16(7):692-7. doi: 10.1016/s0264-410x(97)00253-3.
4
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection.用编码分枝杆菌抗原85A的质粒DNA进行疫苗接种所刺激产生的CD4+和CD8+ T细胞表位组库，比结核分枝杆菌H37Rv感染所刺激产生的更广泛。
Infect Immun. 1998 Apr;66(4):1527-33. doi: 10.1128/IAI.66.4.1527-1533.1998.
5
Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection.用重组痘苗病毒接种可保护小鼠免受结核分枝杆菌感染。
Immunology. 1997 Sep;92(1):6-9. doi: 10.1046/j.1365-2567.1997.00358.x.
6
7
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae.对在母牛分枝杆菌中表达的结核分枝杆菌重组抗原诱导1型免疫反应。
Infect Immun. 1997 May;65(5):1856-62. doi: 10.1128/iai.65.5.1856-1862.1997.
8
9
The pathogenesis of tuberculosis.结核病的发病机制。
Annu Rev Microbiol. 1996;50:259-84. doi: 10.1146/annurev.micro.50.1.259.
10
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.一种结核DNA疫苗的免疫原性及保护效力
Nat Med. 1996 Aug;2(8):893-8. doi: 10.1038/nm0896-893.
Zotero 插件